Article Versions Notes

Huss A, Senel M, Abdelhak A, Mayer B, Kassubek J, Ludolph AC, Otto M, Tumani H. Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies. Biomedicines. 2020; 8(9):312. https://doi.org/10.3390/biomedicines8090312

Huss, André, Makbule Senel, Ahmed Abdelhak, Benjamin Mayer, Jan Kassubek, Albert C. Ludolph, Markus Otto, and Hayrettin Tumani. 2020. "Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies" Biomedicines 8, no. 9: 312. https://doi.org/10.3390/biomedicines8090312

Huss, A., Senel, M., Abdelhak, A., Mayer, B., Kassubek, J., Ludolph, A. C., Otto, M., & Tumani, H. (2020). Longitudinal Serum Neurofilament Levels of Multiple Sclerosis Patients Before and After Treatment with First-Line Immunomodulatory Therapies. Biomedicines, 8(9), 312. https://doi.org/10.3390/biomedicines8090312